The estimated Net Worth of Michael B Wood is at least $6.09 Million dollars as of 16 May 2019. Michael Wood owns over 5,700 units of Steris Plc stock worth over $4,025,700 and over the last 9 years he sold STE stock worth over $1,786,957. In addition, he makes $279,966 as Independent Director at Steris Plc.
Michael has made over 7 trades of the Steris Plc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 5,700 units of STE stock worth $767,619 on 16 May 2019.
The largest trade he's ever made was selling 5,700 units of Steris Plc stock on 16 May 2019 worth over $767,619. On average, Michael trades about 1,946 units every 53 days since 2015. As of 16 May 2019 he still owns at least 16,631 units of Steris Plc stock.
You can see the complete history of Michael Wood stock trades at the bottom of the page.
Michael Wood is the Independent Director at Steris Plc.
As the Independent Director of Steris Plc, the total compensation of Michael Wood at Steris Plc is $279,966. There are 19 executives at Steris Plc getting paid more, with Walter Rosebrough having the highest compensation of $6,458,640.
Michael's mailing address filed with the SEC is C/O CHANCERY HOUSE, 190 WATERSIDE ROAD, HAMILTON INDUSTRIAL PARK, LEICESTER, X0, LE5 1QZ.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough, and John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: